RU2009137946A - Производные пиридазинона для применения в качестве ингибиторов глюкансинтазы - Google Patents

Производные пиридазинона для применения в качестве ингибиторов глюкансинтазы Download PDF

Info

Publication number
RU2009137946A
RU2009137946A RU2009137946/04A RU2009137946A RU2009137946A RU 2009137946 A RU2009137946 A RU 2009137946A RU 2009137946/04 A RU2009137946/04 A RU 2009137946/04A RU 2009137946 A RU2009137946 A RU 2009137946A RU 2009137946 A RU2009137946 A RU 2009137946A
Authority
RU
Russia
Prior art keywords
alkyl
alkenyl
group
candida
spp
Prior art date
Application number
RU2009137946/04A
Other languages
English (en)
Russian (ru)
Inventor
Паулин К. ТИНГ (US)
Паулин К. ТИНГ
Роберт Г. АСЛАНЯН (US)
Роберт Г. АСЛАНЯН
Джианхуа КАО (US)
Джианхуа КАО
Дэвид Вон-Шик КИМ (US)
Дэвид Вон-Шик КИМ
Ронгзе КУАНГ (US)
Ронгзе КУАНГ
Ганг ЖУ (US)
Ганг ЖУ
Роберт Джейсон ХЕРР (US)
Роберт Джейсон Херр
Эндрю Джон ЗИХ (US)
Эндрю Джон ЗИХ
Жинхай ЯНГ (US)
Жинхай ЯНГ
Хепинг ВУ (US)
Хепинг ВУ
Николя ЗОРН (US)
Николя ЗОРН
Original Assignee
Шеринг Корпорейшн (US)
Шеринг Корпорейшн
Олбани Молекюлар Рисерч, Инк. (Us)
Олбани Молекюлар Рисерч, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Шеринг Корпорейшн (US), Шеринг Корпорейшн, Олбани Молекюлар Рисерч, Инк. (Us), Олбани Молекюлар Рисерч, Инк. filed Critical Шеринг Корпорейшн (US)
Publication of RU2009137946A publication Critical patent/RU2009137946A/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D515/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/22Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
RU2009137946/04A 2007-03-15 2008-03-12 Производные пиридазинона для применения в качестве ингибиторов глюкансинтазы RU2009137946A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91817107P 2007-03-15 2007-03-15
US60/918,171 2007-03-15

Publications (1)

Publication Number Publication Date
RU2009137946A true RU2009137946A (ru) 2011-04-20

Family

ID=39525788

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2009137946/04A RU2009137946A (ru) 2007-03-15 2008-03-12 Производные пиридазинона для применения в качестве ингибиторов глюкансинтазы

Country Status (18)

Country Link
US (1) US8232274B2 (https=)
EP (2) EP2137179B1 (https=)
JP (3) JP5147866B2 (https=)
KR (1) KR20100049500A (https=)
CN (1) CN101730692A (https=)
AR (1) AR065721A1 (https=)
AU (1) AU2008227100B2 (https=)
BR (1) BRPI0809238A2 (https=)
CA (1) CA2680583A1 (https=)
CL (1) CL2008000725A1 (https=)
CO (1) CO6220966A2 (https=)
EC (1) ECSP099634A (https=)
IL (1) IL200906A0 (https=)
MX (1) MX2009009948A (https=)
PE (1) PE20081882A1 (https=)
RU (1) RU2009137946A (https=)
TW (1) TW200902516A (https=)
WO (1) WO2008115381A1 (https=)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2681162C (en) 2007-03-15 2015-11-24 Novartis Ag Benzyl and pyridine derivatives as modulators of hedgehog pathway
MX2009009849A (es) * 2007-03-15 2009-09-24 Schering Corp Derivados de piridazinona sustituida con piperazina utiles como inhibidores de glucano sintasa.
BRPI0817211A2 (pt) * 2007-09-20 2017-05-16 Irm Llc composto composições como moduladores da atividade de gpr119
CN102099036B (zh) 2008-06-03 2015-05-27 英特芒尼公司 用于治疗炎性疾患和纤维化疾患的化合物和方法
US20100041663A1 (en) 2008-07-18 2010-02-18 Novartis Ag Organic Compounds as Smo Inhibitors
US20120088769A1 (en) * 2010-10-11 2012-04-12 Axikin Pharmaceuticals, Inc. Salts of arylsulfonamide ccr3 antagonists
FI20115234A0 (fi) 2011-03-08 2011-03-08 Biotie Therapies Corp Uusia pyridatsinoni- ja pyridoniyhdisteitä
GB201111704D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Novel compounds
GB201111705D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Compounds and their use
JO3115B1 (ar) * 2011-08-22 2017-09-20 Takeda Pharmaceuticals Co مركبات بيريدازينون واستخدامها كمثبطات daao
AU2012337781B2 (en) 2011-11-15 2017-07-06 Takeda Pharmaceutical Company Limited Dihydroxy aromatic heterocyclic compound
EP2836482B1 (en) * 2012-04-10 2019-12-25 The Regents of The University of California Compositions and methods for treating cancer
AU2013203000B9 (en) 2012-08-10 2017-02-02 Lantheus Medical Imaging, Inc. Compositions, methods, and systems for the synthesis and use of imaging agents
CN103664795B (zh) * 2012-09-06 2017-10-03 华东理工大学 哒嗪酮类化合物及其用途
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
US11224395B2 (en) 2012-10-05 2022-01-18 Koninklijke Philips N.V. Medical imaging system and method for providing an enhanced X-ray image
GB201222711D0 (en) * 2012-12-17 2013-01-30 Takeda Pharmaceutical Novel compounds
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
CN105612152A (zh) * 2013-08-26 2016-05-25 普渡制药公司 氮杂螺[4.5]癸烷衍生物及其用途
MX382781B (es) 2014-04-02 2025-03-13 Intermune Inc Piridinonas anti-fibroticas.
AU2015251501B2 (en) * 2014-04-24 2019-08-15 Hexima Limited Agents and methods of treatment
RS64770B1 (sr) 2016-03-07 2023-11-30 Agrofresh Inc Sinergistički postupci upotrebe jedinjenja benzoksaborola i gasova za prezerviranje kao antimikrobnih agenasa za useve
US11311501B2 (en) * 2017-03-15 2022-04-26 Lunella Biotech, Inc. Mitoriboscins: mitochondrial-based therapeutics targeting cancer cells, bacteria, and pathogenic yeast
EP3606913B1 (en) 2017-04-03 2022-04-27 Syngenta Participations AG Microbiocidal oxadiazole derivatives
EP3684364A4 (en) 2017-09-18 2021-06-02 Goldfinch Bio, Inc. PYRIDAZINONE AND METHOD OF USE THEREOF
CN109912476A (zh) * 2019-03-27 2019-06-21 南通宝凯化工有限公司 一种异丙氨基磺酰氯的生产工艺
CN112513029B (zh) * 2019-06-21 2023-10-24 上海翰森生物医药科技有限公司 含氮芳基磷氧化物类衍生物、其制备方法和应用
US12509444B2 (en) * 2019-12-06 2025-12-30 Plexxikon Inc. Compounds and methods for CD73 modulation and indications therefor
WO2021222353A1 (en) 2020-04-30 2021-11-04 Gilead Sciences, Inc. Macrocyclic inhibitors of peptidylarginine deiminases
WO2023204124A1 (ja) * 2022-04-20 2023-10-26 日本曹達株式会社 ピリダジノン化合物並びに農園芸用殺菌剤、殺線虫剤、および医療用・動物用抗真菌剤

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS565734B2 (https=) * 1973-02-28 1981-02-06
DE3048487A1 (de) * 1980-12-22 1982-07-29 Cassella Ag, 6000 Frankfurt Basisch substituierte pyridazine, ihre herstellung und ihre verwendung
ES8601972A1 (es) 1985-02-28 1985-11-16 Abello Quimicos Farma Prod Sa Procedimiento de obtencion de 1,2-diazin-3 (2h)-onas con interes farmaceutico
JPH04235975A (ja) * 1991-01-21 1992-08-25 Nissan Chem Ind Ltd ピリダジノン誘導体および害虫防除剤
GB2256587A (en) 1991-06-11 1992-12-16 American Cyanamid Co Acetazolamide in sustained release form
HU227237B1 (en) * 2001-09-27 2010-12-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Substituted alkylpyridazinone derivatives, process for their preparation, pharmaceutical compositions containing them
JPWO2003064422A1 (ja) * 2002-01-31 2005-05-26 第一製薬株式会社 イミダゾ[1,2−a]ピリジン誘導体
DE10216144A1 (de) * 2002-04-12 2003-11-06 Bayer Ag Substituierte 2-Phenyl-3(2H)-Pyridazinone
US20050209278A1 (en) * 2002-04-25 2005-09-22 Mcdonald Joseph J Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
UA77526C2 (en) * 2002-06-07 2006-12-15 Sanofi Aventis Substituted derivatives of 1-piperazineacylpiperidine, a method for the preparation thereof and their use in therapy
CN1905873A (zh) * 2003-11-19 2007-01-31 阵列生物制药公司 Mek的杂环抑制剂及其使用方法
WO2005117909A2 (en) * 2004-04-23 2005-12-15 Exelixis, Inc. Kinase modulators and methods of use
GB0524991D0 (en) * 2005-12-08 2006-01-18 Ge Healthcare Ltd Novel imaging agents for fibrosis
WO2007130383A2 (en) * 2006-04-28 2007-11-15 Northwestern University Compositions and treatments using pyridazine compounds and secretases
MX2009009849A (es) * 2007-03-15 2009-09-24 Schering Corp Derivados de piridazinona sustituida con piperazina utiles como inhibidores de glucano sintasa.

Also Published As

Publication number Publication date
US8232274B2 (en) 2012-07-31
JP5147866B2 (ja) 2013-02-20
JP2010521461A (ja) 2010-06-24
US20090170861A1 (en) 2009-07-02
AU2008227100A1 (en) 2008-09-25
WO2008115381A1 (en) 2008-09-25
EP2137179B1 (en) 2015-09-02
EP2137179A1 (en) 2009-12-30
AU2008227100B2 (en) 2014-01-09
AR065721A1 (es) 2009-06-24
ECSP099634A (es) 2009-10-30
BRPI0809238A2 (pt) 2014-09-09
JP2013014622A (ja) 2013-01-24
EP2586778A2 (en) 2013-05-01
KR20100049500A (ko) 2010-05-12
CL2008000725A1 (es) 2008-11-14
JP2014051529A (ja) 2014-03-20
TW200902516A (en) 2009-01-16
CO6220966A2 (es) 2010-11-19
PE20081882A1 (es) 2008-12-27
CN101730692A (zh) 2010-06-09
IL200906A0 (en) 2010-05-17
EP2586778A3 (en) 2013-07-31
MX2009009948A (es) 2009-09-24
CA2680583A1 (en) 2008-09-25

Similar Documents

Publication Publication Date Title
RU2009137946A (ru) Производные пиридазинона для применения в качестве ингибиторов глюкансинтазы
EP2136808A2 (en) Piperazine-substituted pyridazinone derivatives useful as glucan synthase inhibitors
RU2017128615A (ru) Композиции и способы ингибирования грибковых инфекций
EP2357025A3 (en) Mild leave-on skin care compositions
JP2009543788A5 (https=)
EP2251348A2 (en) Peptides and their use
JP2017517498A5 (https=)
JP2014530801A5 (https=)
CN104041539A (zh) 一种低毒无害杀虫剂
KR20200088351A (ko) 신규한 세포보호 약물
JP2023516648A5 (https=)
CN105102441A (zh) 抗真菌化合物及其用途
JP2018021060A5 (https=)
JPH10338630A (ja) 精油を用いた真菌感染拡散防止剤
CN102068011A (zh) 一种即食梅香鱼的加工方法
JP2009291216A (ja) 飲料組成物
RU2009117207A (ru) Фармацевтическая композиция, включающая производное фениламидина, и способ применения фармацевтической композиции в комбинации с противогрибковым средством
JP5548876B2 (ja) 抗真菌剤
KR20110107040A (ko) 염장해파리의 제조방법
JP4167751B2 (ja) 防カビ剤
JP2011518228A5 (https=)
JP4634517B2 (ja) 出土文化遺物の保存方法
KR101774467B1 (ko) 황칠 함유 전복장아찌의 제조방법 및 이를 이용하여 제조된 전복장아찌
CA2797001A1 (en) Diyne compositions
JP2008113599A (ja) アミノ酸強化発芽穀類の製造方法

Legal Events

Date Code Title Description
FA93 Acknowledgement of application withdrawn (no request for examination)

Effective date: 20110527